ApprovalTrail

Company · Toronto, Ontario, Canada

Apotex Inc.

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
1,379
1,207 authorized now
Natural health products
10
4 active licences
Medical device licences
1
1 active
Notices of Compliance
1,856

Drug products

Authorized products first.

NameDINStatus
24HR NASAL ALLERGY RELIEF02460513Marketed
ACETAMINOPHEN CAPLETS 325 MG02362341Marketed
ACETAMINOPHEN CAPLETS 500 MG02362368Marketed
ACETAMINOPHEN TABLETS USP 325 MG02362422Marketed
ACETAMINOPHEN TABLETS USP 500 MG02362244Marketed
AFLIVU02554178Marketed
AFLIVU02554194Marketed
ALLERGY RELIEF02240266Marketed
ALLERGY REMEDY02375990Marketed
ALLERTIN02390388Marketed
ALYSENA 2102387875Marketed
ALYSENA 2802387883Marketed
ANAFRANIL00324019Marketed
ANAFRANIL00330566Marketed
ANAFRANIL00402591Marketed
APO GLYBURIDE TAB 2.5MG01913654Marketed
APO GLYBURIDE TAB 5MG01913662Marketed
APO PIROXICAM CAP 10MG00642886Marketed
APO PIROXICAM CAP 20MG00642894Marketed
APO PREDNISONE TAB 50MG00550957Marketed
APO PREDNISONE TAB 5MG00312770Marketed
APO-ABACAVIR02396769Marketed
APO-ABIRATERONE FILM COATED TABLETS02491397Marketed
APO-ABIRATERONE FILM COATED TABLETS02491400Marketed
APO-ACEBUTOLOL02147602Marketed
APO-ACEBUTOLOL02147610Marketed
APO-ACEBUTOLOL02147629Marketed
APO-ACETAMINOPHEN00544981Marketed
APO-ACETAMINOPHEN CAPLETS02229873Marketed
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH02229977Marketed
APO-ACETAMINOPHEN EXTRA STRENGTH00545007Marketed
APO-ACYCLOVIR02207621Marketed
APO-ACYCLOVIR02207648Marketed
APO-ACYCLOVIR02207656Marketed
APO-ACYCLOVIR OINTMENT02477130Marketed
APO-ALENDRONATE02248730Marketed
APO-ALENDRONATE/VITAMIN D302454467Marketed
APO-ALENDRONATE/VITAMIN D302454475Marketed
APO-ALFUZOSIN02315866Marketed
APO-ALLOPURINOL TABLETS00402818Marketed
APO-ALLOPURINOL TABLETS00402796Marketed
APO-ALLOPURINOL TABLETS00479799Marketed
APO-ALPRAZ00865397Marketed
APO-ALPRAZ00865400Marketed
APO-ALPRAZ02243611Marketed
APO-ALPRAZ TS02243612Marketed
APO-AMBRISENTAN02475375Marketed
APO-AMBRISENTAN02475383Marketed
APO-AMIODARONE TABLETS02246194Marketed
APO-AMLODIPINE02273373Marketed
APO-AMLODIPINE02273381Marketed
APO-AMLODIPINE-ATORVASTATIN02411253Marketed
APO-AMLODIPINE-ATORVASTATIN02411261Marketed
APO-AMLODIPINE-ATORVASTATIN02411288Marketed
APO-AMLODIPINE-ATORVASTATIN02411296Marketed
APO-AMLODIPINE-ATORVASTATIN02411318Marketed
APO-AMLODIPINE-ATORVASTATIN02411326Marketed
APO-AMLODIPINE-ATORVASTATIN02411334Marketed
APO-AMLODIPINE-ATORVASTATIN02411342Marketed
APO-AMOXI00628115Marketed
APO-AMOXI00628123Marketed
APO-AMOXI00628131Marketed
APO-AMOXI00628158Marketed
APO-AMOXI CLAV02243350Marketed
APO-AMOXI CLAV02243351Marketed
APO-AMOXI CLAV02245623Marketed
APO-AMPHETAMINE XR02445492Marketed
APO-AMPHETAMINE XR02445506Marketed
APO-AMPHETAMINE XR02445514Marketed
APO-AMPHETAMINE XR02445522Marketed
APO-AMPHETAMINE XR02445530Marketed
APO-AMPHETAMINE XR02445549Marketed
APO-ANASTROZOLE02374420Marketed
APO-APIXABAN02487381Marketed
APO-APIXABAN02487403Marketed
APO-APREMILAST02538180Marketed
APO-ARIPIPRAZOLE02471086Marketed
APO-ARIPIPRAZOLE02471094Marketed
APO-ARIPIPRAZOLE02471108Marketed
APO-ARIPIPRAZOLE02471116Marketed
APO-ARIPIPRAZOLE02471124Marketed
APO-ARIPIPRAZOLE02471132Marketed
APO-ATENOL TAB 100MG00773697Marketed
APO-ATENOL TAB 50MG00773689Marketed
APO-ATOMOXETINE02318024Marketed
APO-ATOMOXETINE02318032Marketed
APO-ATOMOXETINE02318040Marketed
APO-ATOMOXETINE02318059Marketed
APO-ATOMOXETINE02318067Marketed
APO-ATOMOXETINE02318075Marketed
APO-ATOMOXETINE02318083Marketed
APO-ATORVASTATIN02295261Marketed
APO-ATORVASTATIN02295288Marketed
APO-ATORVASTATIN02295296Marketed
APO-ATORVASTATIN02295318Marketed
APO-AZATHIOPRINE02242907Marketed
APO-AZELASTINE/FLUTICASONE02540886Marketed
APO-AZITHROMYCIN Z02415542Marketed
APO-BACLOFEN02139332Marketed
APO-BACLOFEN02139391Marketed
APO-BECLOMETHASONE NASAL SPRAY02238796Marketed
APO-BILASTINE TABLETS02549883Marketed
APO-BIMATOPROST RC02403013Marketed
APO-BISOPROLOL02256134Marketed
APO-BISOPROLOL02256177Marketed
APO-BRIMONIDINE-TIMOP02375311Marketed
APO-BRIVARACETAM02538679Marketed
APO-BRIVARACETAM02538687Marketed
APO-BRIVARACETAM02538695Marketed
APO-BRIVARACETAM02538709Marketed
APO-BRIVARACETAM02538717Marketed
APO-BROMAZEPAM02177188Marketed
APO-BROMAZEPAM02177161Marketed
APO-BROMFENAC02537788Marketed
APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE02554690Marketed
APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/202554623Marketed
APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/402554615Marketed
APO-CABERGOLINE02455897Marketed
APO-CANAGLIFLOZIN02564556Marketed
APO-CANAGLIFLOZIN02564564Marketed
APO-CANDESARTAN TABLETS02541289Marketed
APO-CANDESARTAN TABLETS02541297Marketed
APO-CANDESARTAN TABLETS02541300Marketed
APO-CANDESARTAN TABLETS02541319Marketed
APO-CAPTO TAB 100MG00893625Marketed
APO-CAPTO TAB 12.5MG00893595Marketed
APO-CAPTO TAB 50MG00893617Marketed
APO-CEFADROXIL02240774Marketed
APO-CEFEPIME02467496Marketed
APO-CEFEPIME02467518Marketed
APO-CEFUROXIME02244393Marketed
APO-CEFUROXIME02244394Marketed
APO-CELECOXIB02418932Marketed
APO-CELECOXIB02418940Marketed
APO-CEPHALEX00768715Marketed
APO-CEPHALEX00768723Marketed
APO-CETIRIZINE02231603Marketed
APO-CETIRIZINE02453363Marketed
APO-CHLORTHALIDONE00360279Marketed
APO-CICLOPIROX02298953Marketed
APO-CILAZAPRIL02291142Marketed
APO-CILAZAPRIL02291150Marketed
APO-CILAZAPRIL/HCTZ02284987Marketed
APO-CINACALCET02452693Marketed
APO-CINACALCET02452707Marketed
APO-CINACALCET02452715Marketed
APO-CITALOPRAM02246056Marketed
APO-CITALOPRAM02246057Marketed
APO-CLADRIBINE02553295Marketed
APO-CLARITHROMYCIN02274744Marketed
APO-CLARITHROMYCIN02274752Marketed
APO-CLARITHROMYCIN XL02413345Marketed
APO-CLOBAZAM02244638Marketed
APO-CLONAZEPAM02177897Marketed
APO-CLONAZEPAM02177889Marketed
APO-CLOPIDOGREL02252767Marketed
APO-CLOPIDOGREL02398591Marketed
APO-COLESEVELAM02494051Marketed
APO-CYCLOBENZAPRINE02177145Marketed
APO-DABIGATRAN02468891Marketed
APO-DABIGATRAN02468905Marketed
APO-DABIGATRAN02468913Marketed
APO-DAPAGLIFLOZIN02527189Marketed
APO-DAPAGLIFLOZIN02527197Marketed
APO-DAPAGLIFLOZIN-METFORMIN02536153Marketed
APO-DAPAGLIFLOZIN-METFORMIN02536161Marketed
APO-DARIFENACIN02452529Marketed
APO-DARIFENACIN02452510Marketed
APO-DARUNAVIR02487241Marketed
APO-DARUNAVIR02487268Marketed
APO-DASATINIB02470705Marketed
APO-DASATINIB02470713Marketed
APO-DASATINIB02470721Marketed
APO-DASATINIB02481499Marketed
APO-DASATINIB02481502Marketed
APO-DASATINIB TABLETS02562464Marketed
APO-DASATINIB TABLETS02562472Marketed
APO-DASATINIB TABLETS02562480Marketed
APO-DASATINIB TABLETS02562499Marketed
APO-DASATINIB TABLETS02562502Marketed
APO-DEFERASIROX02461544Marketed
APO-DEFERASIROX02461552Marketed
APO-DEFERASIROX02461560Marketed
APO-DEFERASIROX (TYPE J)02485265Marketed
APO-DEFERASIROX (TYPE J)02485273Marketed
APO-DEFERASIROX (TYPE J)02485281Marketed
APO-DESMOPRESSIN02284030Marketed
APO-DESMOPRESSIN02284049Marketed
APO-DESVENLAFAXINE02466988Marketed
APO-DESVENLAFAXINE02466996Marketed
APO-DEXAMETHASONE02250055Marketed
APO-DEXAMETHASONE02261081Marketed
APO-DEXLANSOPRAZOLE02528991Marketed
APO-DEXLANSOPRAZOLE02529025Marketed
APO-DICLO00839175Marketed
APO-DICLO00839183Marketed
APO-DICLO SR02091194Marketed
APO-DICLO SR02162814Marketed
APO-DILTIAZ CD02229526Marketed
APO-DILTIAZ CD02230997Marketed
APO-DILTIAZ CD02230998Marketed
APO-DILTIAZ CD02230999Marketed
APO-DIMETHYL FUMARATE02505762Marketed
APO-DIMETHYL FUMARATE02505770Marketed
APO-DIVALPROEX02239698Marketed
APO-DIVALPROEX02239699Marketed
APO-DIVALPROEX02239700Marketed
APO-DONEPEZIL02362260Marketed
APO-DONEPEZIL02362279Marketed
APO-DORZO-TIMOP02299615Marketed
APO-DOXAZOSIN02240588Marketed
APO-DOXAZOSIN02240589Marketed
APO-DOXAZOSIN02240590Marketed
APO-DOXEPIN02050048Marketed
APO-DOXEPIN02050005Marketed
APO-DOXEPIN02050013Marketed
APO-DOXEPIN02050021Marketed
APO-DOXEPIN02049996Marketed
APO-DOXY00740713Marketed
APO-DOXY-TABS00874256Marketed
APO-DOXYCYCLINE MR02512645Marketed
APO-DOXYLAMINE/B602413248Marketed
APO-DULOXETINE02440423Marketed
APO-DULOXETINE02440431Marketed
APO-DUTASTERIDE02404206Marketed
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR02468247Marketed
APO-ELETRIPTAN TABLETS02518015Marketed
APO-ELETRIPTAN TABLETS02518023Marketed
APO-ELTROMBOPAG02506742Marketed
APO-ELTROMBOPAG02506769Marketed
APO-EMTRICITABINE-TENOFOVIR02452006Marketed
APO-ENALAPRIL02020025Marketed
APO-ENALAPRIL02019884Marketed
APO-ENALAPRIL02019892Marketed
APO-ENALAPRIL02019906Marketed
APO-ENTECAVIR02396955Marketed
APO-ENZALUTAMIDE02562677Marketed
APO-ERLOTINIB02461862Marketed
APO-ERLOTINIB02461870Marketed
APO-ERLOTINIB02461889Marketed
APO-ESCITALOPRAM02295016Marketed
APO-ESCITALOPRAM02295024Marketed
APO-ESLICARBAZEPINE02537931Marketed
APO-ESLICARBAZEPINE02537958Marketed
APO-ESLICARBAZEPINE02537966Marketed
APO-ESLICARBAZEPINE02537974Marketed
APO-ESOMEPRAZOLE02339099Marketed
APO-ESOMEPRAZOLE02339102Marketed
APO-EZETIMIBE02427826Marketed
APO-FAMCICLOVIR02292025Marketed
APO-FAMCICLOVIR02292041Marketed
APO-FAMCICLOVIR02292068Marketed
APO-FELODIPINE02452367Marketed
APO-FELODIPINE02452375Marketed
APO-FELODIPINE02452383Marketed
APO-FLECAINIDE02275538Marketed
APO-FLECAINIDE02275546Marketed
APO-FLUCONAZOLE02237370Marketed
APO-FLUCONAZOLE02237371Marketed
APO-FLUCONAZOLE-15002241895Marketed
APO-FLUOXETINE02216361Marketed
APO-FLUOXETINE02216353Marketed
APO-FLUOXETINE02231328Marketed
APO-FLUTICASONE02294745Marketed
APO-FLUTICASONE HFA02510987Marketed
APO-FLUTICASONE HFA02526557Marketed
APO-FLUTICASONE HFA02528428Marketed
APO-FLUVOXAMINE02231329Marketed
APO-FLUVOXAMINE02231330Marketed
APO-FOSINOPRIL02266008Marketed
APO-FOSINOPRIL02266016Marketed
APO-FROVATRIPTAN02426471Marketed
APO-FUROSEMIDE00362166Marketed
APO-FUROSEMIDE00396788Marketed
APO-FUROSEMIDE00707570Marketed
APO-GABAPENTIN02244304Marketed
APO-GABAPENTIN02244305Marketed
APO-GABAPENTIN02244306Marketed
APO-GABAPENTIN02293358Marketed
APO-GABAPENTIN02293366Marketed
APO-GEFITINIB02468050Marketed
APO-GLICLAZIDE02245247Marketed
APO-GLICLAZIDE MR02297795Marketed
APO-GLICLAZIDE MR02407124Marketed
APO-GRANISETRON02308894Marketed
APO-GUANFACINE XR02523728Marketed
APO-GUANFACINE XR02523736Marketed
APO-GUANFACINE XR02523744Marketed
APO-GUANFACINE XR02523752Marketed
APO-HYDRALAZINE00441619Marketed
APO-HYDRALAZINE00441627Marketed
APO-HYDRALAZINE00441635Marketed
APO-HYDROCHLOROTHIAZIDE00312800Marketed
APO-HYDROCHLOROTHIAZIDE00326844Marketed
APO-HYDROCHLOROTHIAZIDE02327856Marketed
APO-HYDROMORPHONE02364115Marketed
APO-HYDROMORPHONE02364123Marketed
APO-HYDROMORPHONE02364131Marketed
APO-HYDROMORPHONE02364158Marketed
APO-HYDROXYQUINE02246691Marketed

Showing 300 of 1,379 drug products. For the rest, search Health Canada’s database.

Natural health products

Active licences first, newest first.

NameNPNStatus
FERROUS SULFATE 300 mg01912518Active
APO-CAL 25000682047Active
APO-CAL 50000682039Active
APO-K 600mg00602884Active
Nicotine Transdermal Patch80051602Discontinued
Nicotine Transdermal Patch80051600Discontinued
Nicotine Transdermal Patch80051603Discontinued
APO-QUININE 300mg02254522Discontinued
APO-QUININE 200 mg02254514Discontinued
APO-FOLIC 5 mg00426849Cancelled

Medical device licences

Active licences first, newest first.

NameLicenceStatus
CATIONORM PLUS115931Issued (active) · Class 2

Notices of Compliance

Newest first.

  • APO-MYCOPHENOLIC ACIDOctober 2, 2026 · NOC 38400 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-NORETHINDRONESeptember 16, 2026 · NOC 38298 · New Drug Submission (NDS)
  • APO-CYCLOBENZAPRINESeptember 10, 2026 · NOC 38263 · Supplement to a New Drug Submission (SNDS)
  • APO-TADALAFIL PAHSeptember 3, 2026 · NOC 38235 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • AZACITIDINE FOR INJECTIONAugust 27, 2026 · NOC 38192 · Abbreviated New Drug Submission (ANDS)
  • APO-VALACYCLOVIRAugust 27, 2026 · NOC 38212 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-TRIAZIDEAugust 25, 2026 · NOC 38167 · Supplement to a New Drug Submission (SNDS)
  • APO-DIVALPROEXAugust 21, 2026 · NOC 38157 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-VARENICLINEAugust 19, 2026 · NOC 38139 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-TADALAFILAugust 18, 2026 · NOC 38131 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-FELODIPINEAugust 14, 2026 · NOC 38122 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • NORTRIPTYLINEAugust 12, 2026 · NOC 38096 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-SUMATRIPTANAugust 7, 2026 · NOC 38078 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-BILASTINEAugust 6, 2026 · NOC 38060 · Abbreviated New Drug Submission (ANDS)
  • APO-CITALOPRAMJuly 28, 2026 · NOC 37998 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-SUMATRIPTAN-NAPROXEN SODIUMJuly 21, 2026 · NOC 37953 · New Drug Submission (NDS)
  • APO-METOPROLOL; APO-METOPROLOL (TYPE L)July 10, 2026 · NOC 37868 · Supplement to a New Drug Submission (SNDS)
  • APO-DAPAGLIFLOZIN-METFORMINJuly 10, 2026 · NOC 37881 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-TICAGRELORJuly 10, 2026 · NOC 37883 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SEVMIAJune 29, 2026 · NOC 37782 · Abbreviated New Drug Submission (ANDS)
  • APO-CEFUROXIMEJune 24, 2026 · NOC 37764 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-CITALOPRAMJune 23, 2026 · NOC 37752 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-FINGOLIMODJune 18, 2026 · NOC 37738 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • RANVUJune 10, 2026 · NOC 37685 · New Drug Submission (NDS)
  • APO-ROSUVASTATINJune 9, 2026 · NOC 37683 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-DAPAGLIFLOZIN-METFORMINJune 9, 2026 · NOC 37687 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-DOXY; APO-DOXY-TABSJune 5, 2026 · NOC 37662 · Supplement to a New Drug Submission (SNDS)
  • APO-LISDEXAMFETAMINE; APO-LISDEXAMFETAMINE CHEWABLE TABLETSJune 1, 2026 · NOC 37642 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-LEVOTHYROXINEMay 29, 2026 · NOC 37646 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • ACYCLOVIRMay 29, 2026 · NOC 37651 · Supplement to a New Drug Submission (SNDS)
  • APO-DULOXETINEMay 26, 2026 · NOC 37611 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-TAMOXMay 19, 2026 · NOC 37573 · Supplement to a New Drug Submission (SNDS)
  • APO-LEFLUNOMIDEMay 15, 2026 · NOC 37569 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-AMBRISENTANMay 14, 2026 · NOC 37544 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • IHEEZOMay 14, 2026 · NOC 37565 · New Drug Submission (NDS)
  • CYCLOBENZAPRINEMay 11, 2026 · NOC 37516 · Supplement to a New Drug Submission (SNDS)
  • APO-HYDROXYQUINEMay 8, 2026 · NOC 37512 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • LAPELGAMay 5, 2026 · NOC 37474 · Supplement to a New Drug Submission (SNDS)
  • APO-SEMAGLUTIDE INJECTIONMay 1, 2026 · NOC 37448 · Abbreviated New Drug Submission (ANDS)
  • APO-DICLOFENAC POWDERApril 22, 2026 · NOC 37382 · New Drug Submission (NDS)
  • ELFYApril 20, 2026 · NOC 37364 · Abbreviated New Drug Submission (ANDS)
  • APO-ZOPICLONEApril 17, 2026 · NOC 37345 · Supplement to a New Drug Submission (SNDS)
  • APO-CAPECITABINEApril 14, 2026 · NOC 37328 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-APIXABANApril 13, 2026 · NOC 37316 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-BISOPROLOLApril 8, 2026 · NOC 37287 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-POMALIDOMIDEApril 2, 2026 · NOC 37263 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-IMATINIBApril 1, 2026 · NOC 37241 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • DIVALPROEXApril 1, 2026 · NOC 37243 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-ENZALUTAMIDEMarch 30, 2026 · NOC 37209 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-ENZALUTAMIDEMarch 30, 2026 · NOC 37211 · Abbreviated New Drug Submission (ANDS)
  • APO-AMPHETAMINE XRMarch 27, 2026 · NOC 37199 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-GUANFACINE XRMarch 27, 2026 · NOC 37204 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-HYDROXYUREAMarch 27, 2026 · NOC 37222 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • DENOZAMarch 23, 2026 · NOC 37160 · New Drug Submission (NDS)
  • APO-BIMATOPROST RCMarch 16, 2026 · NOC 37107 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-BIMATOPROST RCMarch 16, 2026 · NOC 37111 · Abbreviated New Drug Submission (ANDS)
  • CLOBIVISMarch 13, 2026 · NOC 37105 · New Drug Submission (NDS)
  • APO-NILOTINIBMarch 12, 2026 · NOC 37091 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • IDENOSMarch 11, 2026 · NOC 37133 · New Drug Submission (NDS)
  • APO-AMOXIMarch 5, 2026 · NOC 37044 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-AMOXICILLINMarch 5, 2026 · NOC 37050 · Supplement to a New Drug Submission (SNDS)
  • APO-TRYPTOPHANMarch 3, 2026 · NOC 37022 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-SORAFENIBMarch 3, 2026 · NOC 37027 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-DASATINIBFebruary 27, 2026 · NOC 37008 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-ATORVASTATINFebruary 25, 2026 · NOC 36976 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-DILTIAZ CDFebruary 25, 2026 · NOC 36997 · Supplement to a New Drug Submission (SNDS)
  • GRASTOFILFebruary 24, 2026 · NOC 37014 · Supplement to a New Drug Submission (SNDS)
  • APO-LISDEXAMFETAMINE CAPSULESFebruary 23, 2026 · NOC 36971 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-DASATINIBFebruary 20, 2026 · NOC 36944 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-DOXY; APO-DOXY-TABSFebruary 17, 2026 · NOC 37123 · Supplement to a New Drug Submission (SNDS)
  • ZAMINE 21; ZAMINE 28February 13, 2026 · NOC 36904 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-RAMIPRILFebruary 10, 2026 · NOC 36875 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-OXCARBAZEPINEFebruary 9, 2026 · NOC 36860 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-GABAPENTINFebruary 3, 2026 · NOC 36832 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-SITAGLIPTIN/METFORMIN XRFebruary 2, 2026 · NOC 36813 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MEGESTROLFebruary 2, 2026 · NOC 36826 · Supplement to a New Drug Submission (SNDS)
  • APO-MIRABEGRONJanuary 30, 2026 · NOC 36808 · Abbreviated New Drug Submission (ANDS)
  • APO-RIVAROXABANJanuary 30, 2026 · NOC 36834 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • OVIMA 21; OVIMA 28January 30, 2026 · NOC 36909 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • LAPELGAJanuary 29, 2026 · NOC 36800 · Supplement to a New Drug Submission (SNDS)
  • APO-WARFARINJanuary 22, 2026 · NOC 36779 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-WARFARINJanuary 22, 2026 · NOC 36780 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-LATANOPROSTJanuary 21, 2026 · NOC 36758 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-LEVOMILNACIPRANJanuary 21, 2026 · NOC 36763 · Abbreviated New Drug Submission (ANDS)
  • APO-FLECAINIDEJanuary 13, 2026 · NOC 36723 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-CANAGLIFLOZINJanuary 13, 2026 · NOC 36726 · Abbreviated New Drug Submission (ANDS)
  • APO-DOXY-TABSJanuary 13, 2026 · NOC 36727 · Supplement to a New Drug Submission (SNDS)
  • APO-RILUZOLEJanuary 13, 2026 · NOC 36728 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-NAPROXEN / ESOMEPRAZOLEJanuary 9, 2026 · NOC 36706 · New Drug Submission (NDS)
  • APO-PRUCALOPRIDEJanuary 9, 2026 · NOC 36718 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-METHADONEJanuary 7, 2026 · NOC 36689 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-LABETALOLJanuary 7, 2026 · NOC 36691 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • IBUPROFEN; IBUPROFEN CAPLETSDecember 23, 2025 · NOC 36616 · Supplement to a New Drug Submission (SNDS)
  • APO-APIXABANDecember 22, 2025 · NOC 36598 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-METFORMIN ERDecember 22, 2025 · NOC 36615 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-TOPIRAMATEDecember 19, 2025 · NOC 36597 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-GABAPENTIN; APO-GABAPENTIN TABLETSDecember 19, 2025 · NOC 36599 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • APO-BRIVARACETAMDecember 19, 2025 · NOC 36601 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYADecember 16, 2025 · NOC 36560 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • BAMBEVIDecember 12, 2025 · NOC 36541 · Supplement to a New Drug Submission (SNDS)

The latest 100 of 1,856.

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.